Document is current
Any future updates will be listed below
-
Authors
Nazarov, Pavel A.
Zinovkina, Lyudmila A.
Brezgunova, Anna A.
Lyamzaev, Konstantin G.
Golovin, Andrei V.
Karakozova, Marina V.
Kotova, Elena A.
Plotnikov, Egor Yu.
Zinovkin, Roman A.
Skulachev, Maxim V.
Antonenko, Yuri N.
- License Information
-
More Information
Article History
Received: 4 December 2023
Revised: 30 January 2024
Accepted: 21 February 2024
First Online: 20 March 2024
Ethics declarations
: All the applicable international, national and/or institutional guidelines for the care and use of animals were followed. The protocols for working with animals were approved by the ethical committee of animal research of the Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University (Protocol 3/19 of March 18, 2019).
: <b>Conflict of interests.</b> M. V. Skulachev is the director of the Mitotech company which develops and commercializes drugs based on SkQ-type MTAs. The authors of this work declare that they have no conflicts of interest.
